The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock
- 140 Downloads
To investigate the role of the inducible nitric oxide synthase activation-induced excess nitric oxide formation on the rate of hepatic glucose production during fully resuscitated murine septic shock.
Prospective, controlled, randomized animal study.
University animal research laboratory.
Male C57Bl/6 and B6.129P2-Nos2tm1Lau/J (iNOS−/−) mice.
Fifteen hours after cecal ligation and puncture, anesthetized, mechanically ventilated and instrumented mice (wild-type controls, n = 13; iNOS−/−, n = 12; wild-type mice receiving 5 mg·kg−1 i.p. of the selective iNOS inhibitor GW274150 immediately after cecal ligation and puncture, n = 8) received continuous i.v. hydroxyethylstarch and norepinephrine to achieve normotensive and hyperdynamic hemodynamics.
Measurements and results
Measurements were recorded 18, 21 and 24 h after cecal ligation and puncture. Liver microcirculatory perfusion and capillary hemoglobin O2 saturation (laser Doppler flowmetry and remission spectrophotometry) were well maintained in all groups. Despite significantly lower norepinephrine doses required to achieve the hemodynamic targets, the rate of hepatic glucose production (gas chromatography–mass spectrometry measurements of tissue isotope enrichment during continuous i.v. 1,2,3,4,5,6-13C6-glucose infusion) at 24 h after cecal ligation and puncture was significantly higher in both iNOS−/− and GW274150-treated mice, which was concomitant with a significantly higher hepatic phosphoenolpyruvate carboxykinase activity (spectrophotometry) in these animals.
In normotensive, hyperdynamic septic shock, both pharmacologic and genetic deletion of the inducible nitric oxide synthase allowed maintenance of hepatic glucose production, most likely due to maintained activity of the key regulatory enzyme of gluconeogenesis, phosphoenolpyruvate carboxykinase.
KeywordsLaser Doppler flowmetry Remission spectrophotometry Stable isotope Tracer dilution modeling Phosphoenolpyruvate carboxykinase Glucose-6-phosphatase
- 8.Albuszies G, Radermacher P, Vogt J, Wachter U, Weber S, Schoaff M, Georgieff M, Barth E (2005) Effect of increased cardiac output on hepatic and intestinal microcirculatory blood flow, oxygenation, and metabolism in hyperdynamic murine septic shock. Crit Care Med 33:2332–2338PubMedCrossRefGoogle Scholar
- 17.Träger K, Radermacher P, Rieger KM, Vlatten A, Vogt J, Iber T, Adler J, Wachter U, Grover R, Georgieff M, Šantak B (1999) Norepinephrine and Nω-monomethyl-L-arginine in porcine septic shock: effects on hepatic O2 exchange and energy balance. Am J Respir Crit Care Med 159:1758–1765PubMedGoogle Scholar
- 22.Alderton WK, Angell ADR, Craig C, Dawson J, Garvey EP, Moncada S, Monkhouse J, Rees D, Russell LJ, Schwartz S, Waslidge N, Knowles RG (2005) GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide (iNOS) in vitro and in vivo. Br J Pharmacol 145:310–312CrossRefGoogle Scholar
- 43.Pullamsetti SS, Maring D, Ghofrani HA, Mayer K, Weissmann N, Rosengarten B, Lehner M, Schudt C, Boer R, Grimminger F, Seeger W, Schermuly RT (2006) Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock. Thromb Haemost 95:720–727PubMedGoogle Scholar
- 53.Yamauchi K, Nakajima K, Ikeo S, Nishimura Y, Komatsu M, Aizawa T, Hashizume K (2001) Effects of nipradilol, a nitric oxide-releasing beta-adrenoceptor blocking agent, on phosphoenolpyruvate carboxykinase gene transcription in a rat hepatoma cell line. Jpn J Pharmacol 87:83–85PubMedCrossRefGoogle Scholar
- 63.Wu F, Wilson JX, Tyml K (2003) Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integrative Comp Physiol 285:50–56Google Scholar